There is a theoretical advantage conferred by using rebamipide when compared to other topical treatments for dry eye symptoms due to its anti-inflammatory effect and ability to increase mucin production in the cornea and conjunctiva (15). The gene discussed is MUC5AC; the disease is dry eye syndrome.